<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font29 { font-size : 29; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">patients </span>
   <span class="font30">genes </span>
   <span class="font29">pregnant </span>
   <span class="font29">acute </span>
   <span class="font24">expression </span>
   <span class="font24">subclinical </span>
   <span class="font24">hepatitis </span>
   <span class="font23">HEV </span>
   <span class="font21">immune </span>
   <span class="font21">response </span>
   <span class="font21">infection </span>
   <span class="font20">non-pregnant </span>
   <span class="font20">controls </span>
   <span class="font19">healthy </span>
   <span class="font18">gene </span>
   <span class="font18">terms </span>
   <span class="font18">value </span>
   <span class="font18">women </span>
   <span class="font17">NPR </span>
   <span class="font17">analysis </span>
   <span class="font17">data </span>
   <span class="font17">trimester </span>
   <span class="font16">disease </span>
   <span class="font16">study </span>
   <span class="font16">compared </span>
   <span class="font16">PR--acute </span>
   <span class="font16">expressed </span>
   <span class="font16">pathways </span>
   <span class="font15">infections </span>
   <span class="font15">signaling </span>
   <span class="font15">clinical </span>
   <span class="font15">associated </span>
   <span class="font15">differentially </span>
   <span class="font15">enriched </span>
   <span class="font15">(Fig </span>
   <span class="font15">regulation </span>
   <span class="font15">groups </span>
   <span class="font15">virus </span>
   <span class="font14">PBMCs </span>
   <span class="font14">cell </span>
   <span class="font14">patients. </span>
   <span class="font14">pregnancy </span>
   <span class="font14">[]. </span>
   <span class="font14">RNA </span>
   <span class="font14">Hepatitis </span>
   <span class="font14">levels </span>
   <span class="font14">receptor </span>
   <span class="font14">using </span>
   <span class="font14">Fig </span>
   <span class="font13">{border-style </span>
   <span class="font13">Gene </span>
   <span class="font13">fulminant </span>
   <span class="font13">NPR-acute </span>
   <span class="font13">Viral </span>
   <span class="font13">category </span>
   <span class="font13">controls. </span>
   <span class="font13">identify </span>
   <span class="font13">innate </span>
   <span class="font13">px;} </span>
   <span class="font13">samples </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">additional </span>
   <span class="font13">phase </span>
   <span class="font13">role </span>
   <span class="font13">unique </span>
   <span class="font13">up-regulated </span>
   <span class="font13">Click </span>
   <span class="font13">KEGG </span>
   <span class="font13">LINK </span>
   <span class="font13">PR--SC </span>
   <span class="font13">axis </span>
   <span class="font13">cells </span>
   <span class="font13">file. </span>
   <span class="font13">number </span>
   <span class="font13">patient </span>
   <span class="font13">respective </span>
   <span class="font12">(NPR-control). </span>
   <span class="font12">(PR--acute) </span>
   <span class="font12">Table </span>
   <span class="font12">corresponding </span>
   <span class="font12">pathway </span>
   <span class="font12">patients, </span>
   <span class="font12">used </span>
   <span class="font12">(DOCX) </span>
   <span class="font12">;():–. </span>
   <span class="font12">TLR </span>
   <span class="font12">activation </span>
   <span class="font12">common </span>
   <span class="font12">convalescent </span>
   <span class="font12">human </span>
   <span class="font12">infection. </span>
   <span class="font12">adaptive </span>
   <span class="font12">different </span>
   <span class="font12">groups. </span>
   <span class="font12">high </span>
   <span class="font12">pair-wise </span>
   <span class="font12">related </span>
   <span class="font12">(PR--SC) </span>
   <span class="font12">altered </span>
   <span class="font12">antigen </span>
   <span class="font12">infected </span>
   <span class="font12">liver </span>
   <span class="font12">pregnancy. </span>
   <span class="font12">reads </span>
   <span class="font12">reference </span>
   <span class="font12">seen </span>
   <span class="font12">transcriptome </span>
   <span class="font12">viral </span>
   <span class="font12">Life </span>
   <span class="font12">NOD </span>
   <span class="font12">Sciences </span>
   <span class="font12">Significantly </span>
   <span class="font12">biologic </span>
   <span class="font12">inflammatory </span>
   <span class="font12">over-represented </span>
   <span class="font12">presentation </span>
   <span class="font12">recorded </span>
   <span class="font12">test </span>
   <span class="font11">():–. </span>
   <span class="font11">(GO) </span>
   <span class="font11">:–. </span>
   <span class="font11">Biology </span>
   <span class="font11">Differential </span>
   <span class="font11">EASE </span>
   <span class="font11">Ontology </span>
   <span class="font11">PCR </span>
   <span class="font11">SYBR </span>
   <span class="font11">Std </span>
   <span class="font11">antibodies </span>
   <span class="font11">comparison </span>
   <span class="font11">control </span>
   <span class="font11">error) </span>
   <span class="font11">exhibited </span>
   <span class="font11">fold </span>
   <span class="font11">following </span>
   <span class="font11">group </span>
   <span class="font11">higher </span>
   <span class="font11">pathway, </span>
   <span class="font11">pattern </span>
   <span class="font11">represent </span>
   <span class="font11">response, </span>
   <span class="font11">showed </span>
   <span class="font11">significant </span>
   <span class="font11">time </span>
   <span class="font11">trimesters </span>
   <span class="font11">uniquely </span>
   <span class="font11">values </span>
   <span class="font11">(A) </span>
   <span class="font11">ArankalleVA, </span>
   <span class="font11">DAVID </span>
   <span class="font11">DEFA </span>
   <span class="font11">IFNγ </span>
   <span class="font11">India </span>
   <span class="font11">correlation </span>
   <span class="font11">genes. </span>
   <span class="font11">green-based </span>
   <span class="font11">immunoglobulin </span>
   <span class="font11">increased </span>
   <span class="font11">large </span>
   <span class="font11">modified </span>
   <span class="font11">molecules </span>
   <span class="font11">non-specific </span>
   <span class="font11">severity </span>
   <span class="font11">studies </span>
   <span class="font11">terms. </span>
   <span class="font11">transcript </span>
   <span class="font11">transcripts </span>
   <span class="font11">vertical </span>
   <span class="font11">A). </span>
   <span class="font11">Changes </span>
   <span class="font11">Exact </span>
   <span class="font11">Expression </span>
   <span class="font11">Fisher’s </span>
   <span class="font11">IgG </span>
   <span class="font11">India. </span>
   <span class="font11">NPR-conv </span>
   <span class="font11">Significant </span>
   <span class="font11">affected </span>
   <span class="font11">confirmed </span>
   <span class="font11">defensins </span>
   <span class="font11">differential </span>
   <span class="font11">early </span>
   <span class="font11">horizontal </span>
   <span class="font11">host </span>
   <span class="font11">important </span>
   <span class="font11">included </span>
   <span class="font11">involvement </span>
   <span class="font11">is–log </span>
   <span class="font11">mRNA </span>
   <span class="font11">mapped </span>
   <span class="font11">obtained </span>
   <span class="font11">positive </span>
   <span class="font11">possible </span>
   <span class="font11">present </span>
   <span class="font11">processing </span>
   <span class="font11">production </span>
   <span class="font11">protein </span>
   <span class="font11">px; </span>
   <span class="font11">recognition </span>
   <span class="font11">responses </span>
   <span class="font11">score). </span>
   <span class="font11">symptoms </span>
   <span class="font11">upregulated </span>
   <span class="font11">{font-family </span>
   <span class="font11">&amp;lt;.. </span>
   <span class="font11">ChadhaMS, </span>
   <span class="font11">Health </span>
   <span class="font11">Med </span>
   <span class="font11">Real </span>
   <span class="font11">abundance </span>
   <span class="font11">analysis. </span>
   <span class="font11">anti-HEV </span>
   <span class="font11">blood </span>
   <span class="font11">categories </span>
   <span class="font11">comparisons </span>
   <span class="font11">down-regulated </span>
   <span class="font11">font-size </span>
   <span class="font11">health </span>
   <span class="font11">later </span>
   <span class="font11">mortality </span>
   <span class="font11">normal </span>
   <span class="font11">peptides </span>
   <span class="font11">performed </span>
   <span class="font11">raised </span>
   <span class="font11">similar </span>
   <span class="font11">specific </span>
   <span class="font11">toll-like </span>
   <span class="font11">(B) </span>
   <span class="font11">(NPR-acute) </span>
   <span class="font11">Acute </span>
   <span class="font11">Association </span>
   <span class="font11">DEGs </span>
   <span class="font11">However, </span>
   <span class="font11">Medicine </span>
   <span class="font11">PR--acute, </span>
   <span class="font11">Pregnancy </span>
   <span class="font11">RNA-Seq </span>
   <span class="font11">RNA-seq </span>
   <span class="font11">SA, </span>
   <span class="font11">USA) </span>
   <span class="font11">Venn </span>
   <span class="font11">Virol; </span>
   <span class="font11">[], </span>
   <span class="font11">[–]. </span>
   <span class="font11">alpha </span>
   <span class="font11">based </span>
   <span class="font11">change </span>
   <span class="font11">colors </span>
   <span class="font11">considered </span>
   <span class="font11">convalescence </span>
   <span class="font11">cytokine </span>
   <span class="font11">diagram </span>
   <span class="font11">did </span>
   <span class="font11">disease. </span>
   <span class="font11">double; </span>
   <span class="font11">identified </span>
   <span class="font11">included: </span>
   <span class="font11">like </span>
   <span class="font11">log </span>
   <span class="font11">mediated </span>
   <span class="font11">pathogens </span>
   <span class="font11">sample </span>
   <span class="font11">samples. </span>
   <span class="font11">sequencing </span>
   <span class="font11">subjects </span>
   <span class="font11">trimester, </span>
   <span class="font11">trimester. </span>
   <span class="font11">trimesters. </span>
   <span class="font10">&amp;lt;.). </span>
   <span class="font10">(mean </span>
   <span class="font10">Anti-HEV </span>
   <span class="font10">B). </span>
   <span class="font10">ChobeLP, </span>
   <span class="font10">Comparison </span>
   <span class="font10">Correlation </span>
   <span class="font10">Differences </span>
   <span class="font10">IgM </span>
   <span class="font10">Patients </span>
   <span class="font10">Time-PCR </span>
   <span class="font10">activation, </span>
   <span class="font10">activity </span>
   <span class="font10">assays </span>
   <span class="font10">basis </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">coagulation </span>
   <span class="font10">complement </span>
   <span class="font10">detected </span>
   <span class="font10">enrichment </span>
   <span class="font10">epidemics </span>
   <span class="font10">evident </span>
   <span class="font10">generated </span>
   <span class="font10">induction </span>
   <span class="font10">infection, </span>
   <span class="font10">interaction </span>
   <span class="font10">lupus </span>
   <span class="font10">need </span>
   <span class="font10">negative </span>
   <span class="font10">observations </span>
   <span class="font10">outcome </span>
   <span class="font10">overlapping </span>
   <span class="font10">plot </span>
   <span class="font10">plots </span>
   <span class="font10">production, </span>
   <span class="font10">proportion </span>
   <span class="font10">quality </span>
   <span class="font10">receptors </span>
   <span class="font10">reduced </span>
   <span class="font10">reported </span>
   <span class="font10">respect </span>
   <span class="font10">respectively. </span>
   <span class="font10">response. </span>
   <span class="font10">results </span>
   <span class="font10">self-recovering </span>
   <span class="font10">sequences </span>
   <span class="font10">series </span>
   <span class="font10">solid; </span>
   <span class="font10">suggests </span>
   <span class="font10">systemic </span>
   <span class="font10">titres </span>
   <span class="font10">total </span>
   <span class="font10">vitamin </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(C) </span>
   <span class="font10">(NPR-conv) </span>
   <span class="font10">(green) </span>
   <span class="font10">./j.-...x </span>
   <span class="font10">ERCC </span>
   <span class="font10">FPKM </span>
   <span class="font10">Genetics </span>
   <span class="font10">IL, </span>
   <span class="font10">IRF </span>
   <span class="font10">Immunol; </span>
   <span class="font10">Indian </span>
   <span class="font10">KumarA, </span>
   <span class="font10">MHC </span>
   <span class="font10">Nat </span>
   <span class="font10">Relative </span>
   <span class="font10">Response </span>
   <span class="font10">SOLiD </span>
   <span class="font10">TLRs </span>
   <span class="font10">TaqMan </span>
   <span class="font10">Technologies </span>
   <span class="font10">Technologies, </span>
   <span class="font10">Validation </span>
   <span class="font10">analyses </span>
   <span class="font10">antiviral </span>
   <span class="font10">assays. </span>
   <span class="font10">assess </span>
   <span class="font10">association </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">bold </span>
   <span class="font10">categories. </span>
   <span class="font10">circulating </span>
   <span class="font10">class </span>
   <span class="font10">clustering </span>
   <span class="font10">collection </span>
   <span class="font10">comparative </span>
   <span class="font10">correlated </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokines </span>
   <span class="font10">data. </span>
   <span class="font10">defense </span>
   <span class="font10">differences </span>
   <span class="font10">differentiation </span>
   <span class="font10">documented </span>
   <span class="font10">downregulation </span>
   <span class="font10">earlier </span>
   <span class="font10">em; </span>
   <span class="font10">erythematosus </span>
   <span class="font10">extended </span>
   <span class="font10">failure </span>
   <span class="font10">functional </span>
   <span class="font10">genome </span>
   <span class="font10">help </span>
   <span class="font10">humoral </span>
   <span class="font10">induced </span>
   <span class="font10">interferons </span>
   <span class="font10">involved </span>
   <span class="font10">kit </span>
   <span class="font10">known </span>
   <span class="font10">lower </span>
   <span class="font10">mechanisms </span>
   <span class="font10">million </span>
   <span class="font10">modulation </span>
   <span class="font10">mouse </span>
   <span class="font10">oxidative </span>
   <span class="font10">patterns </span>
   <span class="font10">poor </span>
   <span class="font10">profiles </span>
   <span class="font10">profiling </span>
   <span class="font10">proteins </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">rRNA </span>
   <span class="font10">reduction </span>
   <span class="font10">regulatory </span>
   <span class="font10">respectively </span>
   <span class="font10">restricted </span>
   <span class="font10">revealed </span>
   <span class="font10">sciences </span>
   <span class="font10">severe </span>
   <span class="font10">showing </span>
   <span class="font10">significantly </span>
   <span class="font10">similarity </span>
   <span class="font10">sub-clinical </span>
   <span class="font10">symptomatic </span>
   <span class="font10">transformed </span>
   <span class="font10">trimester-, </span>
   <span class="font10">trimesters, </span>
   <span class="font10">type </span>
   <span class="font10">types </span>
   <span class="font10">understanding </span>
   <span class="font10">upregulation </span>
   <span class="font10">view </span>
   <span class="font10">women, </span>
  </p>
 </body>
</html>
